The US Department of Justice is investigating Medtronic’s marketing practices and reimbursement advice for its surgical ablation devices. You can find the following text buried on page 52 of Medtronic’s Form 10-Q quarterly report on file with the SEC:
On February 9, 2009, the Company received letter notice that the United States Department of Justice in the Southern District of Texas is investigating marketing practices, reimbursement advice of the Company and appropriateness of therapy delivery relating to the Company’s cardiac surgical ablation devices. The Company is in the process of responding to the requests of the government, and will comply as required with the investigation.
The news was first reported in a Bloomberg news story.
Filed under: Uncategorized
